JP2021500081A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021500081A5 JP2021500081A5 JP2020543405A JP2020543405A JP2021500081A5 JP 2021500081 A5 JP2021500081 A5 JP 2021500081A5 JP 2020543405 A JP2020543405 A JP 2020543405A JP 2020543405 A JP2020543405 A JP 2020543405A JP 2021500081 A5 JP2021500081 A5 JP 2021500081A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- granulocytes
- vitro
- cell
- hematopoietic cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023011332A JP2023052704A (ja) | 2016-10-26 | 2023-01-27 | がんを殺傷する細胞 |
| JP2025054346A JP2025114537A (ja) | 2016-10-26 | 2025-03-27 | がんを殺傷する細胞 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1618106.7A GB201618106D0 (en) | 2016-10-26 | 2016-10-26 | Cancer-killing cells |
| PCT/GB2017/053222 WO2018078367A1 (en) | 2016-10-26 | 2017-10-25 | Cancer-killing cells |
| GBPCT/GB2017/053222 | 2017-10-25 | ||
| PCT/GB2018/051073 WO2019081879A1 (en) | 2016-10-26 | 2018-04-24 | CELLS KILLING CANCER |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023011332A Division JP2023052704A (ja) | 2016-10-26 | 2023-01-27 | がんを殺傷する細胞 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021500081A JP2021500081A (ja) | 2021-01-07 |
| JP2021500081A5 true JP2021500081A5 (https=) | 2021-05-20 |
| JP7674102B2 JP7674102B2 (ja) | 2025-05-09 |
Family
ID=57738294
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020543405A Active JP7674102B2 (ja) | 2016-10-26 | 2018-04-24 | がんを殺傷する細胞 |
| JP2023011332A Pending JP2023052704A (ja) | 2016-10-26 | 2023-01-27 | がんを殺傷する細胞 |
| JP2025054346A Pending JP2025114537A (ja) | 2016-10-26 | 2025-03-27 | がんを殺傷する細胞 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023011332A Pending JP2023052704A (ja) | 2016-10-26 | 2023-01-27 | がんを殺傷する細胞 |
| JP2025054346A Pending JP2025114537A (ja) | 2016-10-26 | 2025-03-27 | がんを殺傷する細胞 |
Country Status (11)
| Country | Link |
|---|---|
| US (5) | US11642373B2 (https=) |
| EP (3) | EP3910056A1 (https=) |
| JP (3) | JP7674102B2 (https=) |
| CN (1) | CN111278968A (https=) |
| AU (5) | AU2017349462B2 (https=) |
| CA (1) | CA3115435A1 (https=) |
| DK (1) | DK3532609T3 (https=) |
| ES (1) | ES2886632T3 (https=) |
| GB (1) | GB201618106D0 (https=) |
| IL (4) | IL316666B2 (https=) |
| WO (2) | WO2018078367A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201618106D0 (en) * | 2016-10-26 | 2016-12-07 | Lift Biosciences Ltd | Cancer-killing cells |
| CN115094112A (zh) * | 2022-06-06 | 2022-09-23 | 同济大学 | 一种抗癌效率、癌症进展与预后的标志物及方法 |
| JP2026508019A (ja) * | 2023-03-10 | 2026-03-09 | リフト バイオサイエンシズ リミテッド | 治療用組成物 |
| WO2026062399A1 (en) | 2024-09-19 | 2026-03-26 | Lift Biosciences Ltd | Granulocytes and granulocyte precursors |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ241855A (en) | 1991-03-07 | 1994-04-27 | Gen Hospital Corp | Use of therapeutic cells to obtain cellular response to infection, tumours or autoimmune-generated cells, cells with chimaeric receptors (with binding component and destruction signal), dna encoding the receptor, vectors and antibodies to receptor |
| CA2109729A1 (en) | 1992-03-23 | 1993-09-30 | James G. Bender | In vitro-derived human neutrophil precursor cells |
| WO1993025710A1 (en) * | 1992-06-08 | 1993-12-23 | Gen-Probe Incorporated | Preparation of nucleic acid from mononuclear cells |
| US5846529A (en) | 1993-08-23 | 1998-12-08 | Nexell Therapeutics, Inc. | Infusion of neutrophil precursors for treatment of neutropenia |
| WO1995010291A1 (en) | 1993-10-08 | 1995-04-20 | Cellpro Ii | Methods for collection and cryopreservation of human granulocytes |
| US5599705A (en) | 1993-11-16 | 1997-02-04 | Cameron; Robert B. | In vitro method for producing differentiated universally compatible mature human blood cells |
| US5733541A (en) | 1995-04-21 | 1998-03-31 | The Regent Of The University Of Michigan | Hematopoietic cells: compositions and methods |
| AU2002225959A1 (en) | 2000-11-09 | 2002-05-21 | Mayo Foundation For Medical Education And Research | Absolute lymphocyte recovery and cancer survival |
| US7498171B2 (en) | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| AU2002951082A0 (en) | 2002-08-30 | 2002-09-12 | The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland | Therapeutic cellular agents |
| EP1680080A4 (en) | 2003-10-31 | 2007-10-31 | 3M Innovative Properties Co | NEUTROPHILIC ACTIVATION THROUGH COMPOUNDS TO MODIFY THE IMMUNE RESPONSE |
| CN105168250B (zh) * | 2004-10-25 | 2019-02-05 | 塞勒兰特治疗公司 | 增殖骨髓细胞群体的方法及其应用 |
| US7811815B2 (en) | 2004-11-15 | 2010-10-12 | The Board Of Trustees Of The Leland Stanford Junior University | Therapeutic uses of allogeneic myeloid progenitor cells |
| AU2007278748B2 (en) | 2006-07-24 | 2013-08-15 | The University Of Queensland | Method of producing a population of cells |
| US20080089875A1 (en) * | 2006-10-13 | 2008-04-17 | Zheng Cui | Methods and compositions for the treatment of cancer |
| RU2548741C2 (ru) | 2009-03-05 | 2015-04-20 | Макрокьюэ, Лтд. | Активированная лейкоцитарная композиция |
| US9199028B2 (en) | 2010-01-15 | 2015-12-01 | Memorial Sloan-Kettering Cancer Center | Use of entrained neutrophils to treat metastatic and micrometastatic disease in at risk patients |
| US9862928B2 (en) | 2010-12-03 | 2018-01-09 | Regents Of The University Of Minnesota | Generation of natural killer cells and lymphoid tissue inducer-like (LTi-like) NK-22 cells |
| CN103215340A (zh) | 2012-01-19 | 2013-07-24 | 江苏粒福特生物科技有限公司 | 一种新颖的粒细胞制备及其抗癌活性检测方法 |
| RU2603079C2 (ru) | 2015-03-16 | 2016-11-20 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский радиологический центр" Министерства здравоохранения Российской Федерации (ФГБУ "НМИРЦ" Минздрава России) | Способ активации цитотоксических лимфоцитов человека |
| WO2017161001A1 (en) | 2016-03-15 | 2017-09-21 | Children's Medical Center Corporation | Methods and compositions relating to hematopoietic stem cell expansion |
| GB201618106D0 (en) | 2016-10-26 | 2016-12-07 | Lift Biosciences Ltd | Cancer-killing cells |
| WO2019147187A1 (en) | 2018-01-26 | 2019-08-01 | Agency For Science, Technology And Research | Neutrophil subtypes |
| CN110755449A (zh) | 2019-10-15 | 2020-02-07 | 南方科技大学 | 一种光调控嗜中性粒细胞在治疗癌症的药物中的应用 |
| GB201918341D0 (en) | 2019-12-12 | 2020-01-29 | Lift Biosciences Ltd | Cells for treating infections |
| GB201918313D0 (en) | 2019-12-12 | 2020-01-29 | Lift Biosciences Ltd | Cells for treating cancer |
-
2016
- 2016-10-26 GB GBGB1618106.7A patent/GB201618106D0/en not_active Ceased
-
2017
- 2017-10-25 AU AU2017349462A patent/AU2017349462B2/en active Active
- 2017-10-25 ES ES17794046T patent/ES2886632T3/es active Active
- 2017-10-25 DK DK17794046.7T patent/DK3532609T3/da active
- 2017-10-25 EP EP21169745.3A patent/EP3910056A1/en active Pending
- 2017-10-25 EP EP17794046.7A patent/EP3532609B1/en active Active
- 2017-10-25 WO PCT/GB2017/053222 patent/WO2018078367A1/en not_active Ceased
- 2017-10-25 US US16/345,366 patent/US11642373B2/en active Active
-
2018
- 2018-04-24 IL IL316666A patent/IL316666B2/en unknown
- 2018-04-24 US US16/759,293 patent/US12070473B2/en active Active
- 2018-04-24 IL IL274119A patent/IL274119B2/en unknown
- 2018-04-24 IL IL307836A patent/IL307836B2/en unknown
- 2018-04-24 WO PCT/GB2018/051073 patent/WO2019081879A1/en not_active Ceased
- 2018-04-24 CA CA3115435A patent/CA3115435A1/en active Pending
- 2018-04-24 CN CN201880069094.4A patent/CN111278968A/zh active Pending
- 2018-04-24 IL IL322680A patent/IL322680A/en unknown
- 2018-04-24 AU AU2018356921A patent/AU2018356921B2/en active Active
- 2018-04-24 EP EP18720346.8A patent/EP3701012A1/en active Pending
- 2018-04-24 JP JP2020543405A patent/JP7674102B2/ja active Active
-
2022
- 2022-02-09 AU AU2022200843A patent/AU2022200843C1/en active Active
-
2023
- 2023-01-27 JP JP2023011332A patent/JP2023052704A/ja active Pending
- 2023-03-24 US US18/189,826 patent/US12370216B2/en active Active
- 2023-11-17 US US18/512,933 patent/US20240197776A1/en active Pending
-
2024
- 2024-12-19 AU AU2024278621A patent/AU2024278621A1/en active Pending
-
2025
- 2025-03-27 JP JP2025054346A patent/JP2025114537A/ja active Pending
- 2025-07-02 US US19/257,953 patent/US20250325584A1/en active Pending
- 2025-07-21 AU AU2025205633A patent/AU2025205633A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Investigation of the roles of exosomes in colorectal cancer liver metastasis | |
| Anton et al. | Macrophage-associated mesenchymal stem cells assume an activated, migratory, pro-inflammatory phenotype with increased IL-6 and CXCL10 secretion | |
| Wu et al. | Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties | |
| Guo et al. | Tumour-associated macrophages heterogeneity drives resistance to clinical therapy | |
| Patterson et al. | The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma | |
| Bao et al. | Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells | |
| CN103627673B (zh) | 一种人脑胶质瘤细胞系及其建立方法和应用 | |
| Botchkina et al. | Prostate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2. 24 | |
| Liu et al. | Single-cell clones of liver cancer stem cells have the potential of differentiating into different types of tumor cells | |
| JP2021500081A5 (https=) | ||
| Liao et al. | Androgen receptor in cancer-associated fibroblasts influences stemness in cancer cells | |
| CN101538554A (zh) | 经耐受性筛选的肿瘤干细胞、其制法、应用和试剂盒及其抗原组合物、制法、应用和试剂盒 | |
| Spelat et al. | A worm gel-based 3D model to elucidate the paracrine interaction between multiple myeloma and mesenchymal stem cells | |
| JP2025114537A (ja) | がんを殺傷する細胞 | |
| Ding et al. | Comprehensive review of macrophage models: primary cells and immortalized lines across species | |
| Zhang et al. | Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment | |
| Xiong et al. | HIF1α and HIF2α regulate non-small-cell lung cancer dedifferentiation via expression of Sox2 and Oct4 under hypoxic conditions | |
| Medina et al. | Cobblestone-area forming cells derived from patients with mantle cell lymphoma are enriched for CD133+ tumor-initiating cells | |
| CN102168085A (zh) | 抑制miR-130b基因表达的siRNA和表达载体及其在制备提高肝癌治疗效果的药物中的应用 | |
| Hannig et al. | Control of leucocyte differentiation from embryonic stem cells upon vasculogenesis and confrontation with tumour tissue | |
| Yin et al. | Sodium citrate pretreatment enhances CAR-T cell persistence and anti-tumor efficacy through inhibition of calcium signaling | |
| CN108704138A (zh) | TGF-β1抑制剂和GM-CSF抑制剂与吉西他滨联合在制备治疗癌症药物中的用途 | |
| Tang et al. | Identification and characterization of the cellular subclones that contribute to the pathogenesis of mantle cell lymphoma | |
| Sharrow et al. | Tumor-Associated Macrophages Expand Chemoresistant, Ovarian Cancer Stem-Like Cells | |
| Suraeva et al. | Characteristics of Mel Ibr melanoma line subclone after treatment with chicken embryo extract |